Growth hormone (Genotonorm® or Omnitrope®) ( DrugBank: Growth hormone )

---

2 diseases

ID	Disease name (Link within this page)	Number of trials
78	Hypopituitarism	1
193	Prader-Willi syndrome	1

78. Hypopituitarism

---

Clinical trials : 494 /  Drugs : 385 - (DrugBank : 49) / Drug target genes : 44 - Drug target pathways : 100

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01298180 (ClinicalTrials.gov)	January 2009	6/11/2009	Is There a Sensibility Increased in the Growth Hormone at Child With Prader-Willi Syndrome?	Is There a Sensibility Increased in the Growth Hormone at Child With Prader-Willi Syndrome?	Prader-Willi Syndrome;Growth Hormone Deficiency	Drug: Growth hormone (Genotonorm® or Omnitrope®);Procedure: DEXA, blood tests, H.G.P.O, osseous age.;Procedure: biopsy	University Hospital, Toulouse	NULL	Completed	1 Year	5 Years	All	111	Phase 4	France

193. Prader-Willi syndrome

---

Clinical trials : 111 /  Drugs : 120 - (DrugBank : 30) / Drug target genes : 51 - Drug target pathways : 103

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01298180 (ClinicalTrials.gov)	January 2009	6/11/2009	Is There a Sensibility Increased in the Growth Hormone at Child With Prader-Willi Syndrome?	Is There a Sensibility Increased in the Growth Hormone at Child With Prader-Willi Syndrome?	Prader-Willi Syndrome;Growth Hormone Deficiency	Drug: Growth hormone (Genotonorm® or Omnitrope®);Procedure: DEXA, blood tests, H.G.P.O, osseous age.;Procedure: biopsy	University Hospital, Toulouse	NULL	Completed	1 Year	5 Years	All	111	Phase 4	France